SCHEMBL29611423

SCHEMBL29611423

CC(C)[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 16/20 0.61
▸ NPY1R P25929 10/20 0.61
▸ NPY5R Q15761 8/20 0.61
▸ NPY2R P49146 6/20 0.61
▸ OPRD1 P41143 1/20 0.52
▸ BACE1 P56817 1/20 0.48
▸ BACE2 Q9Y5Z0 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29649760 0.97 NPY4R (0.61) NPY4RNPY1RNPY5RNPY2ROPRD1
SCHEMBL29649734 0.97 NPY4R (0.61) NPY4RNPY1RNPY5RNPY2ROPRD1
SCHEMBL29779431 0.93 NPY4R (0.69) NPY4RNPY1RNPY5RNPY2ROPRD1
SCHEMBL30844026 0.93 NPY4R (0.64) NPY4RNPY1RNPY5RNPY2R
SCHEMBL30496421 0.92 NPY4R (0.59) NPY4RNPY1RNPY5RNPY2ROPRD1
SCHEMBL29602482 0.92 NPY4R (0.59) NPY4RNPY1RNPY5RNPY2ROPRD1
SCHEMBL29757876 0.92 NPY4R (0.57) NPY4RNPY1RNPY5RNPY2R
SCHEMBL30331385 0.91 NPY4R (0.61) NPY4RNPY1RNPY5RNPY2ROPRD1
SCHEMBL29839246 0.91 NPY4R (0.59) NPY4RNPY1RNPY5RNPY2ROPRD1
SCHEMBL29559026 0.91 NPY4R (0.60) NPY4RNPY1RNPY5RNPY2ROPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12419824-B2 Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes LUBRIZOL ADVANCED MATERIALS, INC. (US) 2025-09-23 — — US disclosed
US-20220183950-A1 COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES LUBRIZOL ADVANCED MATERIALS, INC. (US) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220183950-A1 COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES TYR, TELO2, MTX2 NPY4R 124/4885NPY1R 65/4885NPY5R 48/4885
US-12419824-B2 Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes TYR, TELO2, MTX2 NPY4R 124/4885NPY1R 65/4885NPY5R 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback